Vaccine design and delivery approaches for COVID-19

被引:21
|
作者
Shahzamani, Kiana [1 ]
Mahmoudian, Fatemeh [2 ]
Ahangarzadeh, Shahrzad [3 ]
Ranjbar, Mohammad Mehdi [4 ]
Beikmohammadi, Leila [5 ,6 ]
Bahrami, Samira [7 ]
Mohammadi, Elmira [8 ,9 ]
Esfandyari, Sahar [10 ]
Alibakhshi, Abbas [11 ]
Javanmard, Shaghayegh Haghjooy [8 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Gastroenterol & Hepatol Res Ctr IGHRC, Esfahan, Iran
[2] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Mol Med, Tehran, Iran
[3] Isfahan Univ Med Sci, Infect Dis & Trop Med Res Ctr, Esfahan, Iran
[4] Agr Res Educ & Extens Org AREEO, Razi Vaccine & Serum Res Inst, Karaj, Iran
[5] Erasmus MC, Dept Biochem, Rotterdam, Netherlands
[6] Univ Tehran Med Sci, Stem Cell & Regenerat Med Ctr Excellence, Tehran 141556559, Iran
[7] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Biotechnol Dept, Tehran, Iran
[8] Isfahan Univ Med Sci, Appl Physiol Res Ctr, Cardiovasc Res Inst, Dept Physiol, Esfahan, Iran
[9] Isfahan Univ Med Sci, Core Res Facil, Esfahan, Iran
[10] Univ Tehran Med Sci, Sch Med, Dept Anat, Tehran, Iran
[11] Hamadan Univ Med Sci, Mol Med Res Ctr, Hamadan, Hamadan, Iran
关键词
COVID-19; SARS-CoV-2; Vaccine; Vaccine design; Vaccine delivery; RECEPTOR-BINDING DOMAIN; SARS; SARS-COV-2; PROTEIN; VIRUS; IMMUNOGENICITY; STRATEGIES; MUTATIONS; SYSTEM; COV;
D O I
10.1016/j.intimp.2021.108086
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
COVID-19 is still a deadly disease that remains yet a major challenge for humans. In recent times, many large pharmaceutical and non-pharmaceutical companies have invested a lot of time and cost in fighting this disease. In this regard, today's scientific knowledge shows that designing and producing an effective vaccine is the best possible way to diminish the disease burden and dissemination or even eradicate the disease. Due to the urgent need, many vaccines are now available earlier than scheduled. New technologies have also helped to produce much more effective vaccines, although the potential side effects must be taken into account. Thus, in this review, the types of vaccines and vaccine designs made against COVID-19, the vaccination programs, as well as the delivery methods and molecules that have been used to deliver some vaccines that need a carrier will be described.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design
    Rezaei, Shokouh
    Sefidbakht, Yahya
    Uskokovic, Vuk
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (06)
  • [22] An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada
    Kholina, Ksenia
    Harmon, Shawn H. E.
    Graham, Janice E.
    PLOS ONE, 2022, 17 (12):
  • [23] MACHINE LEARNING APPROACHES FOR COVID-19 MISINFORMATION AND VACCINE ACCEPTANCE IN AFRICA
    Swen, Melody
    O'Neill, Rhys
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 302 - 303
  • [24] Practice report: an Alberta Metis model for COVID-19 vaccine delivery
    King, Keith D.
    Bartel, Reagan
    James, Ashton
    MacDonald, Shannon E.
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2022, 113 (01): : 81 - 86
  • [25] Optimal COVID-19 Vaccination Strategies with Limited Vaccine and Delivery Capabilities
    Santini S.
    ACM Transactions on Computing for Healthcare, 2021, 2 (04):
  • [26] Safety of COVID-19 vaccine delivery by dentists: An observational cohort study
    Kagawa, Keita
    Kuroda, Hidetaka
    Kaneko, Dai
    Imura, Miki
    Imaizumi, Uno
    Kido, Kanta
    Tsukimoto, Shota
    Kurata, Shinji
    Kishimoto, Naotaka
    Sanuki, Takuro
    JOURNAL OF DENTAL SCIENCES, 2023, 18 (02) : 613 - 617
  • [27] Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications
    Prabhakar, Pranav Kumar
    Khurana, Navneet
    Vyas, Manish
    Sharma, Vikas
    Batiha, Gaber El-Saber
    Kaur, Harpreet
    Singh, Jashanpreet
    Kumar, Deepak
    Sharma, Neha
    Kaushik, Ajeet
    Kumar, Raj
    PHARMACEUTICS, 2023, 15 (02)
  • [28] COVID-19 vaccine hesitancy: a midwifery survey into attitudes towards the COVID-19 vaccine
    Funlayo Odejinmi
    Rebecca Mallick
    Christina Neophytou
    Kade Mondeh
    Megan Hall
    Claire Scrivener
    Katie Tibble
    Mary Turay-Olusile
    Nandita Deo
    Doreen Oforiwaa
    Rita Osayimwen
    BMC Public Health, 22
  • [29] COVID-19 vaccine hesitancy: a midwifery survey into attitudes towards the COVID-19 vaccine
    Odejinmi, Funlayo
    Mallick, Rebecca
    Neophytou, Christina
    Mondeh, Kade
    Hall, Megan
    Scrivener, Claire
    Tibble, Katie
    Turay-Olusile, Mary
    Deo, Nandita
    Oforiwaa, Doreen
    Osayimwen, Rita
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [30] VIEWPOINT: COVID-19 Understanding COVID-19 vaccine efficacy
    Lipsitch, Marc
    Dean, Natalie E.
    SCIENCE, 2020, 370 (6518) : 763 - 765